1
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T26564 |
ADCI
SGB-017,SGB017,SGB 017 |
||
ADCI is an inhibitor of voltage-activated sodium channels and N-methyl-D-aspartate (NMDA)-receptor-gated channels. Inhibition of sodium channels by ADCI was voltage dependent. High doses of ADCI increased dopamine metabolism in the prefrontal cortex and/o |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01283 |
Glypican 3/GPC3 Protein, Human, Recombinant (His)
SGBS1,DGSX,SGBS,MXR7,OCI-5,Glypican 3,... |
Human | HEK293 Cells |
Glypican 3/GPC3 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 62 kDa and the accession number is P51654-1. | |||
TMPY-05805 |
Glypican 3/GPC3 Protein, Human, Recombinant (S495A, hFc)
GTR2-2,SGBS,DGSX,SGBS1,OCI-5,SGB,... |
Human | HEK293 Cells |
Glypican 3/GPC3 Protein, Human, Recombinant (S495A, hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 86.46 kDa and the accession number is I6QTG3. | |||
TMPK-00337 |
GPC3 Protein-VLP, Human, Recombinant (aa 438-554)
OCI-5,SDYS,SGB,OCI5,MXR7,GTR2-2,GPC3,Glypican 3, |
Human | HEK293 Cells |
Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed. GPC3 Protein-VLP, Human, Recombinant (aa 438-554) is expressed in HEK293 mammalian cells. The predicted molecular weight is 21.5 kDa and th... | |||
TMPY-05106 |
Glypican 3/GPC3 Protein, Human, Recombinant (His), Biotinylated
SGB,GTR2-2,SDYS,DGSX,OCI-5,Glypican 3,SGBS... |
Human | HEK293 Cells |
Glypican 3/GPC3 Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 62.2 kDa and the accession number is P51654-1. | |||
TMPY-06877 |
Glypican 3/GPC3 Protein, Human, Recombinant (His & Avi), Biotinylated
DGSX,SDYS,GTR2-2,SGBS,Glypican 3,OCI-5,SGB... |
Human | HEK293 Cells |
Glypican 3/GPC3 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 64.05 kDa and the accession number is P51654-1. | |||
TMPY-05806 |
Glypican 3/GPC3 Protein, Human, Recombinant (S495A, mFc)
DGSX,SGBS,SGB,GTR2-2,SGBS1,Glypic... |
Human | HEK293 Cells |
Glypican 3/GPC3 Protein, Human, Recombinant (S495A, mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 86.11 kDa and the accession number is I6QTG3. | |||
TMPK-00336 |
GPC3 Protein-VLP, Human, Recombinant
Glypican 3,SGB,SGBS1SDYS,DGSX,OCI-5,OCI5,G... |
Human | E. coli |
Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed. GPC3 Protein-VLP, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 14 kDa and the accession ... |